Researchers Optimistic about Genomics Funding, Rate Illumina and Life Tech Best in Class | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Despite a gray forecast for National Institutes of Health funding, researchers have a relatively positive outlook on genomics funding, a recent survey conducted jointly by GenomeWeb and investment firm Mizuho Securities has found.

Respondents to the survey also ranked Illumina, Life Technologies, and Roche as the companies with the best products in genomics research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: CRISPR-based barcodes to trace cell lineages, and more.

The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.

French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.